Real-World Study Backs Mepolizumab in Rhinosinusitis With Nasal Polyps
(MedPage Today) -- Mepolizumab (Nucala) improved outcomes for adults with severe chronic rhinosinusitis with nasal polyps (CRSwNP) and put about one in five on the way to remission, a real-life study from Italy showed. The nasal polyp score dropped...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.